Based on the mice model, we found both the Aldo concentration and AIF-1 expression in the aorta were significantly increased in the CKD group, and Spir (Aldo inhibitor) could reduce the AIF-1 expression. This evidence concerns the gene AIF1 and chronic kidney disease.